Free shipping on all orders over $ 500

VU0155094

Cat. No. M30547

All AbMole products are for research use only, cannot be used for human consumption.

VU0155094 Structure
Synonym:

ML397

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

VU0155094 is a positive allosteric modulator with differential activity at the various group III mGluRs.

Chemical Information
Molecular Weight 436.52
Formula C24H24N2O4S
CAS Number 731006-86-3
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Nidhi Jalan-Sakrikar, et al. ACS Chem Neurosci. Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7

Related GluR Products
VU0650786

VU0650786 is a potent and selective CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 (mGlu3 NAM), with an IC50 of 392 nM.

NS-102

NS-102 is a selective kainate (GluK2) receptor antagonist.

VU0424465 

VU0424465 is a potent and partial PAM (positive allosteric modulator)-agonist for mGlu5 mediated iCa2+ mobilization.

ATPA 

ATPA is a selective glutamate receptor GluR5 activator with EC50s of 0.66, 9.5, 1.4, 23, 32, 18, and 14 μM for GluR5wt, GluR5(S741M), GluR5(S721T), GluR5(S721T, S741M), GluR5(S741A), GluR5(S741L), and GluR5(S741V), respectively.

(R)-CPP 

(R)-CPP is a highly potent NMDA receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: VU0155094, ML397 supplier, GluR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.